AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectively interact with misfolded proteins that are common in a range of neurodegenerative diseases. The company is developing Crenezumab, a humanized, conformation-specific monoclonal antibody, which is in Phase II clinical prevention trial for the treatment of Alzheimer's disease (AD). It is also developing ACI-24, an anti-Abeta vaccine candidate that is in Phase II clinical study for AD, as well as completed Phase Ib clinical study for Down syndrome; ACI-35, an anti-Tau vaccine candidate that has completed Phase Ib clinical study; and Tau- positron emission tomography (PET) imaging tracer, which is in Phase II clinical study. In addition, the company is researching and developing small molecule Tau aggregation inhibitors for AD and NeuroOrphan indications. Further, it has discovery and preclinical stage molecules targeting range of neurodegenerative diseases, which include diagnostics targeting TDP-43, alpha-synuclein, and NLRP3. AC Immune SA has license agreements and collaborations with Genentech, Inc.; Biogen International GmbH; Janssen Pharmaceuticals, Inc.; Life Molecular Imaging SA; Eli Lilly and Company; and WuXi Biologics. The company was incorporated in 2003 and is headquartered in Lausanne, Switzerland.. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of AC Immune SA.
AC Immune SA business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of AC Immune SA are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of AC Immune SA , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of AC Immune SA including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of AC Immune SA and all latest updates of the company are provided.
The 2025 version of AC Immune SA report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
NA
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 AC Immune SA- Key Facts
2.2 AC Immune SA- Geographic Locations
2.3 AC Immune SA- Subsidiaries and Affiliates
2.4 AC Immune SA- Business Divisions
2.5 AC Immune SA- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. AC Immune SA Strategic Analysis Review
3.1 AC Immune SA- Key Strategies
3.2 AC Immune SA- Company Outlook Statement
3.3 AC Immune SA- SWOT Analysis
3.3.1 AC Immune SA- Key Strengths
3.3.2 AC Immune SA- Key Weaknesses
3.3.3 AC Immune SA- Potential Opportunities
3.3.4 AC Immune SA- Potential Threats
3.4 AC Immune SA- Key Competitors
4. Business Description of the Company
4.1 AC Immune SA- Business Overview
4.2 AC Immune SA- Operations by Segment
5 Products and Services Details
5.1 AC Immune SA- Key Products
5.2 AC Immune SA- Key Service Areas
5.3 AC Immune SA- Key Brands
6 Company Developments
6.1 AC Immune SA- Company History
6.2 AC Immune SA- Latest Developments
7 Financial Analysis
7.1 AC Immune SA- Income Statements
7.2 AC Immune SA- Balance Sheet
7.3 AC Immune SA- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 AC Immune SA- Direct Competitors
8.2 AC Immune SA- Competitor Financial Ratios comparison
8.3 AC Immune SA- Competitor Stock Charts Comparison
8.4 AC Immune SA- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
NA
Get Free Sample
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
Reach Out to Us
Industries
Resources
Company
Sign up for Offers & Promotions
- Connect with us
- +91 630 95 25755
- sales@swotreports.com
-
Chat on WhatsApp
